A carregar...
Spironolactone, a possible selective androgen receptor modulator, should be used with caution in patients with metastatic carcinoma of the prostate
The authors report the case of an 80-year-old man who had heavily pretreated castration refractory carcinoma of the prostate and heart failure. Following the introduction of spironolactone to manage his heart failure, the patient experienced clinical and biochemical progression of his prostate cance...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3291010/ https://ncbi.nlm.nih.gov/pubmed/22665559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr.11.2011.5238 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|